- $1.94bn
- $2.24bn
- $2.95bn
- 96
- 98
- 80
- 100
2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 817 | 812 | 1,241 | 1,558 | 2,947 |
Cost of Revenue | |||||
Gross Profit | 547 | 551 | 462 | 568 | 891 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 489 | 530 | 1,018 | 1,287 | 2,424 |
Operating Profit | 328 | 282 | 224 | 271 | 524 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 276 | 244 | 187 | 240 | 504 |
Provision for Income Taxes | |||||
Net Income After Taxes | 274 | 244 | 186 | 239 | 493 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 274 | 244 | 185 | 227 | 470 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 274 | 244 | 185 | 227 | 470 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.95 | 1.62 | 0.918 | 1.51 | 3.23 |
Dividends per Share |